Navigation Links
Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association
Date:6/8/2009

About Otelixizumab

Otelixizumab is a novel monoclonal antibody being developed for the treatment of type 1 diabetes and other autoimmune diseases. Otelixizumab targets CD3, a T lymphocyte receptor involved in normal cell signaling. Otelixizumab has not yet been approved for marketing. Data suggest that the antibody may work in patients with type 1 diabetes who have residual beta cells by blocking the function of effector T cells that mistakenly attack and destroy insulin-producing beta cells, while stimulating regulatory T cells that are understood to protect against effector T cell damage, thus preserving the beta cells' ability to make insulin.

About Tolerx

Tolerx is a biopharmaceutical company engaged in the discovery and development of novel therapies for immune-mediated diseases. The company's pipeline includes its lead candidate, otelixizumab, an anti-CD3 monoclonal antibody partnered with GlaxoSmithKline in Phase 3 development for the treatment of type 1 diabetes; a Phase 1 candidate, MTRX1011A, an anti-CD4 antibody that is being developed in collaboration with Genentech, Inc. for the treatment of autoimmune indications; and two pre-clinical candidates, TRX518 and TRX385, that enhance immune responses and are being evaluated for potential benefit in the treatment of cancer, chronic viral diseases, and as vaccine adjuvants. Tolerx is a privately held company headquartered in Cambridge, MA USA. For more information, please visit www.tolerx.com.


'/>"/>
SOURCE TolerRx, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Tolerx Initiates Dosing of Otelixizumab, a Novel Type 1 Diabetes Agent, in DEFEND, a Phase 3 Clinical Trial
2. Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial
3. Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting
4. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
5. Micromet Presents Update on Blinatumomabs Response Rate and Duration in a Phase 1 Study in Non-Hodgkins Lymphoma Patients
6. Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting
7. Entremed Presents Results of ENMD-2076 Phase 1 Study in Advanced Cancer Patients
8. Proteolix Presents Phase 1b/2 Clinical Data for Carfilzomib in Advanced Solid Tumor Patients at the 2009 ASCO Annual Meeting
9. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
10. TYRX Presents Early Clinical Results from AIGISRX(TM) Antibacterial Envelope Retrospective Registry
11. Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology 2009 Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... 26, 2014 Research and Markets ... Meter Industry Report 2014 " report to their ... Report 2014 is a professional and in-depth study on ... The report provides a basic overview of ... structure. The glucose meter market analysis is provided for ...
(Date:8/26/2014)... Aug. 26, 2014   Quanta Aesthetic Lasers , the ... America , expands the offerings in their robust product ... is now available for shipping to medical spas, clinics, and ... The QuantaShape is manufactured in the Chianti hills ... Project .  The device was previously sold as both the ...
(Date:8/26/2014)... Aug. 26, 2014 Research and ... "Global Veterinary Diagnostics Market 2014-2018" report ... include various tests, which are used to detect ... and biomedical researchers are mainly availing these diagnostic ... Acid/Ribonucleic Acid testing), immunodiagnostics, clinical chemistry, and hematology. ...
Breaking Medicine Technology:Global Glucose Meter Industry Report 2014 2Global Glucose Meter Industry Report 2014 3Another Italian Beauty Joins the Quanta Aesthetic Lasers Lineup 2Global Veterinary Diagnostics Market 2014-2018: Key Vendors are Abaxis, Heska, IDEXX Laboratories, Mindray Medical, VCA Antech and Zoetis 2Global Veterinary Diagnostics Market 2014-2018: Key Vendors are Abaxis, Heska, IDEXX Laboratories, Mindray Medical, VCA Antech and Zoetis 3
... (Nasdaq: CADX ), a biopharmaceutical company focused ... use in the hospital setting, today reported financial ... September 30, 2008., The company also provided ... two Phase III product candidates -- Acetavance(TM), an,intravenous ...
... Denmark, November 6 Bavarian,Nordic has completed a clinical ... in HIV infected subjects that confirms the excellent,safety profile ... report,of this study will be submitted to the FDA ... under the RFP-3 contract. The clinical safety,report constitutes a ...
Cached Medicine Technology:Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 2Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 3Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 4Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 5Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 6Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 7Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 8Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE(R) 2
(Date:8/27/2014)... 2014 Top10BestSEOHosting.com compares many popular ... are the most recommended suppliers for webmasters who ... , “GreenGeeks and GoDaddy provide stellar hosting products ... they have managed to provide a wide range ... ease of use that helps diminish the inherent ...
(Date:8/27/2014)... and Ontario, Canada (PRWEB) August 27, 2014 ... through a huge transformation as was revealed in a ... 2014 survey were not just surprising but astonishing as ... survey carried out online interviewed existing members on the ... Facebook. , According to Kaly, 10yeargap marketing department manager," ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Discover Leadership ... personal and corporate transformation through their comprehensive leadership programs. ... Moses has unparalleled experience in the realm of outcome-focused ... this expertise in a new webinar series titled, “A ... Seller.” The first of this two part webinar is ...
(Date:8/27/2014)... NY (PRWEB) August 27, 2014 Overcoming a ... he finally found his niche. The Women’s Radio Network, WRNW1, ... for his continued support and dedication to the WRNW1 family. ... able to have such a positive atmosphere.” After KC Armstrong ... Sirius XM of the Howard Stern show, “Howard 100 News,” ...
(Date:8/27/2014)... 2014 Casey Diekman, assistant professor of ... is helping to gain greater insight into the biological ... Evolution has harmonized the behavior of humans and all ... the cycle of light and dark experienced each day ... hormone production related to natural patterns of sleep/wake behavior ...
Breaking Medicine News(10 mins):Health News:Excellent Hosting Suppliers Recommended By Top10BestSEOHosting.com 2Health News:Survey Reveals Younger Women Dating Older Men 2Health News:Survey Reveals Younger Women Dating Older Men 3Health News:Barb Moses, Vice President of Discover Leadership Training, Announces New Webinar Titled, “A Women’s Guide to Making Her Life Story a Bestseller” 2Health News:The Women's Radio Network, WRNW1, Signs KC Armstrong to a Multi-Million Dollar Contract 2Health News:NJIT Researcher Receives New NSF Funding to Study Fundamental Rhythms of Life 2Health News:NJIT Researcher Receives New NSF Funding to Study Fundamental Rhythms of Life 3Health News:NJIT Researcher Receives New NSF Funding to Study Fundamental Rhythms of Life 4
... bars are completely interchangeable in the Medifast 5 & ... Medifast, Inc.,(NYSE: MED ), a leading portion-controlled weight-loss ... featuring a great crunchy,taste and a new formula that ... bar flavors include Chocolate Mint Crunch,Peanut Butter Crunch, and ...
... pathway may affect esophageal cancer risk, a dangerous and rapidly ... The University of Texas M. D. Anderson Cancer Center. , ... at the association between variations in genes related to microRNAs ... of Cancer Prevention Research , a journal of the ...
... Health Care recognizes health care ... Award, OAKLAND, Calif., Nov. 5 The California ... the "Director,s,Right Care Initiative Award" for its outstanding work ... presentation of the award and is,part of the DMHC,s ...
... the key factors that health professionals need to be aware ... Researchers from the University of Sheffield, UK, found considerable differences ... 16 viewed a series of sexual scenarios. , "The ... likely to see their partner,s point of view and were ...
... employers cost-effective, turnkey solution,to improve employee health., ... now have a,cost-effective solution to reduce employee ... competitive by attracting and retaining talent. Today,HealthFitness ... - a powerful combination of its eHealth ...
... CITY, China, Nov. 5 /Xinhua-PRNewswire-FirstCall/,-- China Pharma Holdings, ... manufactures, and markets generic and branded,bio-pharmaceutical products in ... 2008 results on Friday, November 7, 2008. In ... at 10:00 a.m. EST on Friday,November 7, 2008 ...
Cached Medicine News:Health News:Medifast Adds New Crunchy Bars to Product Line 2Health News:Gene variations alter risk of esophageal cancer 2Health News:Kaiser Permanente Honored for Success in Diabetes and Heart Disease Prevention 2Health News:Kaiser Permanente Honored for Success in Diabetes and Heart Disease Prevention 3Health News:Kaiser Permanente Honored for Success in Diabetes and Heart Disease Prevention 4Health News:Alcohol advice needs to play a greater role in sex education for teenagers 2Health News:Alcohol advice needs to play a greater role in sex education for teenagers 3Health News:HealthFitness Launches New Preventive Health Solution for Small Employers 2Health News:HealthFitness Launches New Preventive Health Solution for Small Employers 3Health News:China Pharma Holdings, Inc. to Host Third Quarter 2008 Earnings Conference Call at 10 a.m. EST Friday November 7, 2008 2Health News:China Pharma Holdings, Inc. to Host Third Quarter 2008 Earnings Conference Call at 10 a.m. EST Friday November 7, 2008 3
Inquire...
... Reference Series 2000 Pipette is a synonym ... compact and robust design, and superior operating ... to operate the measuring stroke and blow-out ... features:Eppendorf "pipette/tip" system ensures utmost accuracy and ...
... The Eppendorf Reference Series 2000 Pipette ... smooth stroke, a compact and robust design, ... button is used to operate the measuring ... the tip. Product features:Eppendorf "pipette/tip" system ensures ...
... Reference Series 2000 Pipette is a synonym ... compact and robust design, and superior operating ... to operate the measuring stroke and blow-out ... features:Eppendorf "pipette/tip" system ensures utmost accuracy and ...
Medicine Products: